MONTE ROSA THERAPEUTICS, INC.

Analyst Reco. Monte Rosa Therapeutics, Inc.

Equities

GLUE

US61225M1027

Market Closed - Nasdaq Other stock markets 03:59:44 2024-06-04 pm EDT			5-day change	1st Jan Change
4 ^USD	+0.50%		-4.31%	-29.20%

May. 30	Monte Rosa Therapeutics Names Three Insiders to Leadership Team	MT
May. 30	Monte Rosa Therapeutics, Inc. Announces Executive Promotions	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating	Apr. 29	MT
Wedbush Starts Monte Rosa Therapeutics With Outperform Rating, $11 Price Target	Feb. 15	MT
Credit Suisse Trims Monte Rosa Therapeutics' Price Target to $11 From $12, Keeps Neutral Rating	23-03-17	MT
Wells Fargo Upgrades Monte Rosa Therapeutics to Overweight From Equalweight, Price Target at $18	23-01-03	MT
UBS Initiates Coverage on Monte Rosa Therapeutics With Buy Rating, $22 Price Target	22-10-13	MT
Jefferies Starts Monte Rosa Therapeutics at Buy With $20 Price Target	22-08-15	MT
Piper Sandler Adjusts Price Target on Monte Rosa Therapeutics to $21 From $40, Reiterates Overweight Rating	22-05-12	MT
Credit Suisse Initiates Monte Rosa Therapeutics at Neutral, $19 Price Target	22-04-28	MT
Berenberg Bank Adjusts Monte Rosa Therapeutics' Price Target to $28 From $32, Maintains Buy Rating	22-03-30	MT
Wells Fargo Starts Monte Rosa Therapeutics at Equalweight With $19 Price Target	22-02-09	MT
Guggenheim Adjusts Price Target for Monte Rosa Therapeutics to $35 From $40, Maintains Buy Rating	22-01-03	MT
Berenberg Bank Initiates Coverage on Monte Rosa Therapeutics With Buy Rating, $32 Price Target	21-11-17	MT
MONTE ROSA THERAPEUTICS : SVB Leerink Starts Monte Rosa Therapeutics at Market Perform with $20 Price Target	21-10-14	MT
MONTE ROSA THERAPEUTICS : JPMorgan Initiates Monte Rosa Therapeutics at Overweight Rating With $38 Price Target	21-07-19	MT
MONTE ROSA THERAPEUTICS : Cowen Initiates Coverage on Monte Rosa Therapeutics With Outperform Rating	21-07-19	MT
MONTE ROSA THERAPEUTICS : Piper Sandler Starts Monte Rosa Therapeutics at Overweight With $40 Price Target	21-07-19	MT
MONTE ROSA THERAPEUTICS : Guggenheim Starts Monte Rosa Therapeutics at Buy With $30 Price Target	21-07-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer